Publicité
Publicité
APLT
Applied Therapeutics, Inc. Common Stock
0.10
USDSponsorisé
0.00
+0.80%
09 janv., 15:57 UTC -5
Fermé
Après-marché
0.10
0.00
0.00%
APLT Rapports sur les bénéfices
Ratio de surprise positive
APLT a dépassé 15 des 27 dernières estimations.
56%
Prochain rapport
Date du prochain rapport
13 avr. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.11
Variation implicite de Q3 25 (Revenue/ EPS)
-100.00%
/-15.38%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-133.33%
Applied Therapeutics, Inc. Common Stock earnings per share and revenue
On 13 nov. 2025, APLT reported earnings of -0.13 USD per share (EPS) for Q3 25, beating the estimate of -0.14 USD, resulting in a 8.96% surprise. Revenue reached 1.00 million, compared to an expected 340.00 mille, with a 194.12% difference. The market reacted with a -70.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analystes forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an baisse of -15.38% EPS, and baisse of -100.00% in Revenue from the last quarter.
FAQ
What were Applied Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Applied Therapeutics, Inc. Common Stock reported EPS of -$0.13, beating estimates by 8.96%, and revenue of $1.00M, 194.12% above expectations.
How did the market react to Applied Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -70.33%, changed from $0.91 before the earnings release to $0.27 the day after.
When is Applied Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 13 avr. 2026.
What are the forecasts for Applied Therapeutics, Inc. Common Stock's next earnings report?
Based on 6
analystes, Applied Therapeutics, Inc. Common Stock is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité